start_structures/Ligand_Substrate/Ligand_Complex_Stripped/2GK_4LEN.pdb
 OpenBabel08222315203D

 23 24  0  0  1  0  0  0  0  0999 V2000
   -2.5950   58.2080   15.2170 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1910   57.3410   16.3360 C   0  0  2  0  0  0  0  0  0  0  0  0
   -0.7930   57.6100   16.8930 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4390   57.0510   17.9270 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3210   55.8540   15.9810 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6740   55.4260   16.0120 O   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7320   51.6720   12.1340 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5320   50.9340   11.9830 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3090   51.4130   12.4420 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.5110   53.4470   13.2520 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5590   54.7170   14.2110 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1190   53.4550   13.6920 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6260   55.8690   14.8460 B   0  0  0  0  0  0  0  0  0  0  0  0
   -6.3010   52.6980   13.1150 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.2270   54.9310   14.0290 S   0  0  0  0  0  0  0  0  0  0  0  0
   -8.7350   52.9010   12.7640 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8080   52.8550   13.6050 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8350   53.6110   13.1240 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6910   52.7980   12.7460 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8560   56.3360   13.6360 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.5380   56.9450   15.4730 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7560   53.3590   12.1320 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7330   51.5500   12.9160 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  6  0  0  0
  2  3  1  0  0  0  0
  3  4  2  0  0  0  0
  5  6  1  0  0  0  0
  5  2  1  0  0  0  0
  6 13  1  0  0  0  0
  7  8  2  0  0  0  0
  7 16  1  0  0  0  0
  8  9  1  0  0  0  0
  9 14  2  0  0  0  0
 10 14  1  0  0  0  0
 10 15  1  0  0  0  0
 10 16  2  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 11 15  1  0  0  0  0
 12 14  1  0  0  0  0
 12 17  1  0  0  0  0
 13 20  1  0  0  0  0
 13 21  1  0  0  0  0
 17 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 22  2  0  0  0  0
 19 23  1  0  0  0  0
M  END
>  <HEADER>
    HYDROLASE/HYDROLASE INHIBITOR           26-JUN-13   4LEN              

>  <TITLE>
    CTX-M-9 IN COMPLEX WITH THE BROAD SPECTRUM INHIBITOR 3-(2-            
   2 CARBOXYVINYL)BENZO(B)THIOPHENE-2-BORONIC ACID                        

>  <COMPND>
    MOL_ID: 1;                                                            
   2 MOLECULE: BETA-LACTAMASE;                                            
   3 CHAIN: A, B;                                                         
   4 FRAGMENT: CTX-M9;                                                    
   5 SYNONYM: BETA-LACTAMASE CTX-M, BETA-LACTAMASE CTX-M-9A, BETALACTAMASE
   6 CTX-M-9, CTX-M-9 BETA-LACTAMASE, CTX-M-9 EXTENDED-SPECTRUM BETA-     
   7 LACTAMASE;                                                           
   8 EC: 3.5.2.6;                                                         
   9 ENGINEERED: YES;                                                     
  10 MUTATION: YES                                                        

>  <SOURCE>
    MOL_ID: 1;                                                            
   2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI;                               
   3 ORGANISM_TAXID: 562;                                                 
   4 STRAIN: K12;                                                         
   5 GENE: BLACTX-M-9, BLACTX-M-9A, BLACTX-M-9A BLACTX-M-9 BLACTX-M-9B,   
   6 BLACTX-M-9B;                                                         
   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
   8 EXPRESSION_SYSTEM_TAXID: 469008;                                     
   9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3);                                
  10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;                              
  11 EXPRESSION_SYSTEM_PLASMID: PET-9A                                    

>  <KEYWDS>
    BINDING SITES, STRUCTURE BASE DRUG DESIGN, DRUG DISCOVERY, MOLECULAR, 
   2 ENZYME INHIBITORS, BETA LACTAMASES, BORONIC ACIDS, BROAD SPECTRUM,   
   3 BACTERIAL RESISTANCE, DOUBLE PERTURBATION CYCLE ANALYSIS,            
   4 THERMODYNAMICS, STRUCTURE ACTIVITY RELATIONSHIP, HYDROLASE-HYDROLASE 
   5 INHIBITOR COMPLEX                                                    

>  <EXPDTA>
    X-RAY DIFFRACTION                                                     

>  <AUTHOR>
    D.TONDI                                                               

>  <REVDAT>
   4   17-JUL-19 4LEN    1       REMARK LINK                              
   3   19-OCT-16 4LEN    1       TITLE                                    
   2   16-JUL-14 4LEN    1       JRNL                                     
   1   18-JUN-14 4LEN    0                                                

>  <JRNL>
      AUTH   D.TONDI,A.VENTURELLI,R.BONNET,C.POZZI,B.K.SHOICHET,M.P.COSTI 
      TITL   TARGETING CLASS A AND C SERINE BETA-LACTAMASES WITH A        
      TITL 2 BROAD-SPECTRUM BORONIC ACID DERIVATIVE.                      
      REF    J.MED.CHEM.                   V.  57  5449 2014              
      REFN                   ISSN 0022-2623                               
      PMID   24882105                                                     
      DOI    10.1021/JM5006572                                            

>  <REMARK>
   2                                                                      
   2 RESOLUTION.    1.50 ANGSTROMS.                                       
   3                                                                      
   3 REFINEMENT.                                                          
   3   PROGRAM     : REFMAC 5.7.0032                                      
   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
   3               : NICHOLLS,WINN,LONG,VAGIN                             
   3                                                                      
   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD                            
   3                                                                      
   3  DATA USED IN REFINEMENT.                                            
   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50                           
   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 19.39                          
   3   DATA CUTOFF            (SIGMA(F)) : NULL                           
   3   COMPLETENESS FOR RANGE        (%) : 97.5                           
   3   NUMBER OF REFLECTIONS             : 65055                          
   3                                                                      
   3  FIT TO DATA USED IN REFINEMENT.                                     
   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
   3   R VALUE     (WORKING + TEST SET) : 0.160                           
   3   R VALUE            (WORKING SET) : 0.159                           
   3   FREE R VALUE                     : 0.182                           
   3   FREE R VALUE TEST SET SIZE   (%) : 5.000                           
   3   FREE R VALUE TEST SET COUNT      : 3455                            
   3                                                                      
   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
   3   TOTAL NUMBER OF BINS USED           : 20                           
   3   BIN RESOLUTION RANGE HIGH       (A) : 1.50                         
   3   BIN RESOLUTION RANGE LOW        (A) : 1.54                         
   3   REFLECTION IN BIN     (WORKING SET) : 4329                         
   3   BIN COMPLETENESS (WORKING+TEST) (%) : 88.22                        
   3   BIN R VALUE           (WORKING SET) : 0.1800                       
   3   BIN FREE R VALUE SET COUNT          : 223                          
   3   BIN FREE R VALUE                    : 0.2250                       
   3                                                                      
   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
   3   PROTEIN ATOMS            : 3907                                    
   3   NUCLEIC ACID ATOMS       : 0                                       
   3   HETEROGEN ATOMS          : 34                                      
   3   SOLVENT ATOMS            : 774                                     
   3                                                                      
   3  B VALUES.                                                           
   3   FROM WILSON PLOT           (A**2) : NULL                           
   3   MEAN B VALUE      (OVERALL, A**2) : 10.21                          
   3   OVERALL ANISOTROPIC B VALUE.                                       
   3    B11 (A**2) : -0.01000                                             
   3    B22 (A**2) : 0.00000                                              
   3    B33 (A**2) : 0.00000                                              
   3    B12 (A**2) : 0.00000                                              
   3    B13 (A**2) : 0.00000                                              
   3    B23 (A**2) : 0.00000                                              
   3                                                                      
   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
   3   ESU BASED ON R VALUE                            (A): 0.079         
   3   ESU BASED ON FREE R VALUE                       (A): 0.076         
   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.043         
   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.114         
   3                                                                      
   3 CORRELATION COEFFICIENTS.                                            
   3   CORRELATION COEFFICIENT FO-FC      : 0.959                         
   3   CORRELATION COEFFICIENT FO-FC FREE : 0.947                         
   3                                                                      
   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
   3   BOND LENGTHS REFINED ATOMS        (A):  4097 ; 0.006 ; 0.019       
   3   BOND LENGTHS OTHERS               (A):  NULL ;  NULL ;  NULL       
   3   BOND ANGLES REFINED ATOMS   (DEGREES):  5589 ; 1.313 ; 1.977       
   3   BOND ANGLES OTHERS          (DEGREES):  NULL ;  NULL ;  NULL       
   3   TORSION ANGLES, PERIOD 1    (DEGREES):   545 ; 5.816 ; 5.000       
   3   TORSION ANGLES, PERIOD 2    (DEGREES):   166 ;39.085 ;24.578       
   3   TORSION ANGLES, PERIOD 3    (DEGREES):   683 ;11.686 ;15.000       
   3   TORSION ANGLES, PERIOD 4    (DEGREES):    31 ; 8.006 ;15.000       
   3   CHIRAL-CENTER RESTRAINTS       (A**3):   662 ; 0.085 ; 0.200       
   3   GENERAL PLANES REFINED ATOMS      (A):  3089 ; 0.006 ; 0.021       
   3   GENERAL PLANES OTHERS             (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL       
   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
   3                                                                      
   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  2133 ; 0.414 ; 0.769       
   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  2665 ; 0.753 ; 1.148       
   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  1964 ; 0.448 ; 0.858       
   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
   3                                                                      
   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
   3                                                                      
   3  NCS RESTRAINTS STATISTICS                                           
   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
   3                                                                      
   3  TLS DETAILS                                                         
   3   NUMBER OF TLS GROUPS  : NULL                                       
   3                                                                      
   3  BULK SOLVENT MODELLING.                                             
   3   METHOD USED : MASK                                                 
   3   PARAMETERS FOR MASK CALCULATION                                    
   3   VDW PROBE RADIUS   : 1.20                                          
   3   ION PROBE RADIUS   : 0.80                                          
   3   SHRINKAGE RADIUS   : 0.80                                          
   3                                                                      
   3  OTHER REFINEMENT REMARKS: NULL                                      
   4                                                                      
   4 4LEN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
 100                                                                      
 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JUL-13.                  
 100 THE DEPOSITION ID IS D_1000080533.                                   
 200                                                                      
 200 EXPERIMENTAL DETAILS                                                 
 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
 200  DATE OF DATA COLLECTION        : SEP-04                             
 200  TEMPERATURE           (KELVIN) : NULL                               
 200  PH                             : 8.8                                
 200  NUMBER OF CRYSTALS USED        : 1                                  
 200                                                                      
 200  SYNCHROTRON              (Y/N) : Y                                  
 200  RADIATION SOURCE               : ALS                                
 200  BEAMLINE                       : 8.3.1                              
 200  X-RAY GENERATOR MODEL          : NULL                               
 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
 200  WAVELENGTH OR RANGE        (A) : NULL                               
 200  MONOCHROMATOR                  : MIRRORS                            
 200  OPTICS                         : MIRRORS                            
 200                                                                      
 200  DETECTOR TYPE                  : CCD                                
 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 210                   
 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000                           
 200  DATA SCALING SOFTWARE          : SCALEPACK                          
 200                                                                      
 200  NUMBER OF UNIQUE REFLECTIONS   : 82595                              
 200  RESOLUTION RANGE HIGH      (A) : 1.350                              
 200  RESOLUTION RANGE LOW       (A) : 20.000                             
 200  REJECTION CRITERIA  (SIGMA(I)) : -3.000                             
 200                                                                      
 200 OVERALL.                                                             
 200  COMPLETENESS FOR RANGE     (%) : 85.9                               
 200  DATA REDUNDANCY                : NULL                               
 200  R MERGE                    (I) : NULL                               
 200  R SYM                      (I) : NULL                               
 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
 200                                                                      
 200 IN THE HIGHEST RESOLUTION SHELL.                                     
 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL                     
 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : NULL                     
 200  COMPLETENESS FOR SHELL     (%) : NULL                               
 200  DATA REDUNDANCY IN SHELL       : NULL                               
 200  R MERGE FOR SHELL          (I) : NULL                               
 200  R SYM FOR SHELL            (I) : NULL                               
 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
 200                                                                      
 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
 200 SOFTWARE USED: CNS                                                   
 200 STARTING MODEL: PDB ENTRY 1YM1                                       
 200                                                                      
 200 REMARK: NULL                                                         
 280                                                                      
 280 CRYSTAL                                                              
 280 SOLVENT CONTENT, VS   (%): 38.63                                     
 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00                     
 280                                                                      
 280 CRYSTALLIZATION CONDITIONS: 1.4 M POTASSIUM PHOSPHATE BUFFER USING   
 280  MICROSEEDING TECHNIQUES, VAPOR DIFFUSION, HANGING DROP,             
 280  TEMPERATURE 295K, PH 8.8                                            
 290                                                                      
 290 CRYSTALLOGRAPHIC SYMMETRY                                            
 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1                         
 290                                                                      
 290      SYMOP   SYMMETRY                                                
 290     NNNMMM   OPERATOR                                                
 290       1555   X,Y,Z                                                   
 290       2555   -X,Y+1/2,-Z                                             
 290                                                                      
 290     WHERE NNN -> OPERATOR NUMBER                                     
 290           MMM -> TRANSLATION VECTOR                                  
 290                                                                      
 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
 290 RELATED MOLECULES.                                                   
 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
 290   SMTRY2   2  0.000000  1.000000  0.000000       53.29750            
 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
 290                                                                      
 290 REMARK: NULL                                                         
 300                                                                      
 300 BIOMOLECULE: 1, 2                                                    
 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
 300 BURIED SURFACE AREA.                                                 
 350                                                                      
 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
 350                                                                      
 350 BIOMOLECULE: 1                                                       
 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
 350 APPLY THE FOLLOWING TO CHAINS: A                                     
 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
 350                                                                      
 350 BIOMOLECULE: 2                                                       
 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
 350 APPLY THE FOLLOWING TO CHAINS: B                                     
 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
 465                                                                      
 465 MISSING RESIDUES                                                     
 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
 465                                                                      
 465   M RES C SSSEQI                                                     
 465     GLN B    25                                                      
 465     THR B    26                                                      
 470                                                                      
 470 MISSING ATOM                                                         
 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
 470 I=INSERTION CODE):                                                   
 470   M RES CSSEQI  ATOMS                                                
 470     GLU A 201    CD   OE1  OE2                                       
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: COVALENT BOND LENGTHS                                      
 500                                                                      
 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
 500                                                                      
 500 STANDARD TABLE:                                                      
 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3)               
 500                                                                      
 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
 500                                                                      
 500  M RES CSSEQI ATM1   RES CSSEQI ATM2   DEVIATION                     
 500    VAL A  57   C     LEU A  59   N       0.274                       
 500    GLY A 238   C     ASP A 240   N       0.282                       
 500    VAL B  57   C     LEU B  59   N       0.258                       
 500    GLY B 238   C     ASP B 240   N       0.244                       
 500                                                                      
 500 REMARK: NULL                                                         
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: TORSION ANGLES                                             
 500                                                                      
 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
 500                                                                      
 500 STANDARD TABLE:                                                      
 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
 500                                                                      
 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
 500                                                                      
 500  M RES CSSEQI        PSI       PHI                                   
 500    CYS A  69     -137.92     48.05                                   
 500    VAL A 103     -128.58   -105.87                                   
 500    ASN A 106       58.60   -140.56                                   
 500    SER A 220     -125.07   -105.64                                   
 500    CYS B  69     -137.68     47.74                                   
 500    VAL B 103     -127.91   -106.50                                   
 500    SER B 220     -126.72   -104.54                                   
 500                                                                      
 500 REMARK: NULL                                                         
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: MAIN CHAIN PLANARITY                                       
 500                                                                      
 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY                       
 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER                 
 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME;                     
 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;                            
 500 I=INSERTION CODE).                                                   
 500                                                                      
 500  M RES CSSEQI        ANGLE                                           
 500    VAL A  57         12.44                                           
 500    PRO A 252         11.36                                           
 500                                                                      
 500 REMARK: NULL                                                         
 600                                                                      
 600 HETEROGEN                                                            
 600                                                                      
 600 THE STARTING MATERIAL USED FOR CHEMICAL REACTION CORRESPONDS TO THE  
 600 COMPUND: 3-[2-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-        
 600 BENZO[B]THIOPHEN-3-YL]-ACRYLIC ACID. SEE ALSO LINK RECORDS.          
 800                                                                      
 800 SITE                                                                 
 800 SITE_IDENTIFIER: AC1                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2GK A 300                 
 800                                                                      
 800 SITE_IDENTIFIER: AC2                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2GK B 300                 

>  <DBREF>
 4LEN A   25   290  UNP    Q9L5C8   Q9L5C8_ECOLX    29    291             
 4LEN B   25   290  UNP    Q9L5C8   Q9L5C8_ECOLX    29    291             

>  <SEQRES>
   1 A  263  GLN THR SER ALA VAL GLN GLN LYS LEU ALA ALA LEU GLU          
   2 A  263  LYS SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASP          
   3 A  263  THR ALA ASP ASN THR GLN VAL LEU TYR ARG GLY ASP GLU          
   4 A  263  ARG PHE PRO MET CYS SER THR SER LYS VAL MET ALA ALA          
   5 A  263  ALA ALA VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU          
   6 A  263  LEU ASN GLN PRO VAL GLU ILE LYS PRO ALA ASP LEU VAL          
   7 A  263  ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR          
   8 A  263  MET THR LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR          
   9 A  263  SER ASP ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU          
  10 A  263  GLY GLY PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE          
  11 A  263  GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR          
  12 A  263  LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR          
  13 A  263  THR PRO ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR          
  14 A  263  LEU GLY HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU          
  15 A  263  VAL THR TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER          
  16 A  263  ILE ARG ALA GLY LEU PRO THR SER TRP THR ALA GLY ASP          
  17 A  263  LYS THR GLY SER GLY ASP TYR GLY THR THR ASN ASP ILE          
  18 A  263  ALA VAL ILE TRP PRO GLN GLY ARG ALA PRO LEU VAL LEU          
  19 A  263  VAL THR TYR PHE THR GLN PRO GLN GLN ASN ALA GLU SER          
  20 A  263  ARG ARG ASP VAL LEU ALA SER ALA ALA ARG ILE ILE ALA          
  21 A  263  GLU GLY LEU                                                  
   1 B  263  GLN THR SER ALA VAL GLN GLN LYS LEU ALA ALA LEU GLU          
   2 B  263  LYS SER SER GLY GLY ARG LEU GLY VAL ALA LEU ILE ASP          
   3 B  263  THR ALA ASP ASN THR GLN VAL LEU TYR ARG GLY ASP GLU          
   4 B  263  ARG PHE PRO MET CYS SER THR SER LYS VAL MET ALA ALA          
   5 B  263  ALA ALA VAL LEU LYS GLN SER GLU THR GLN LYS GLN LEU          
   6 B  263  LEU ASN GLN PRO VAL GLU ILE LYS PRO ALA ASP LEU VAL          
   7 B  263  ASN TYR ASN PRO ILE ALA GLU LYS HIS VAL ASN GLY THR          
   8 B  263  MET THR LEU ALA GLU LEU SER ALA ALA ALA LEU GLN TYR          
   9 B  263  SER ASP ASN THR ALA MET ASN LYS LEU ILE ALA GLN LEU          
  10 B  263  GLY GLY PRO GLY GLY VAL THR ALA PHE ALA ARG ALA ILE          
  11 B  263  GLY ASP GLU THR PHE ARG LEU ASP ARG THR GLU PRO THR          
  12 B  263  LEU ASN THR ALA ILE PRO GLY ASP PRO ARG ASP THR THR          
  13 B  263  THR PRO ARG ALA MET ALA GLN THR LEU ARG GLN LEU THR          
  14 B  263  LEU GLY HIS ALA LEU GLY GLU THR GLN ARG ALA GLN LEU          
  15 B  263  VAL THR TRP LEU LYS GLY ASN THR THR GLY ALA ALA SER          
  16 B  263  ILE ARG ALA GLY LEU PRO THR SER TRP THR ALA GLY ASP          
  17 B  263  LYS THR GLY SER GLY ASP TYR GLY THR THR ASN ASP ILE          
  18 B  263  ALA VAL ILE TRP PRO GLN GLY ARG ALA PRO LEU VAL LEU          
  19 B  263  VAL THR TYR PHE THR GLN PRO GLN GLN ASN ALA GLU SER          
  20 B  263  ARG ARG ASP VAL LEU ALA SER ALA ALA ARG ILE ILE ALA          
  21 B  263  GLU GLY LEU                                                  

>  <HET>
 2GK  A 300      17                                                       
 2GK  B 300      17                                                       

>  <HETNAM>
     2GK (2E)-3-[2-(DIHYDROXYBORANYL)-1-BENZOTHIOPHEN-3-YL]PROP-          
   2 2GK  2-ENOIC ACID                                                    

>  <FORMUL>
   3  2GK    2(C11 H9 B O4 S)                                             
   5  HOH   *774(H2 O)                                                    

>  <HELIX>
   1   1 SER A   27  GLY A   41  1                                  15    
   2   2 CYS A   69  THR A   71  5                                   3    
   3   3 SER A   72  GLU A   85  1                                  14    
   4   4 GLN A   89  ASN A   92  5                                   4    
   5   5 LYS A   98  LEU A  102  5                                   5    
   6   6 ILE A  108  VAL A  113  5                                   6    
   7   7 LEU A  119  SER A  130  1                                  12    
   8   8 ASP A  131  LEU A  142  1                                  12    
   9   9 GLY A  144  ILE A  155  1                                  12    
  10  10 PRO A  167  THR A  171  5                                   5    
  11  11 THR A  182  LEU A  195  1                                  14    
  12  12 GLY A  200  GLY A  213  1                                  14    
  13  13 SER A  220  LEU A  225  5                                   6    
  14  14 ARG A  275  GLY A  289  1                                  15    
  15  15 ALA B   28  GLY B   41  1                                  14    
  16  16 CYS B   69  THR B   71  5                                   3    
  17  17 SER B   72  GLU B   85  1                                  14    
  18  18 GLN B   89  ASN B   92  5                                   4    
  19  19 LYS B   98  LEU B  102  5                                   5    
  20  20 ILE B  108  VAL B  113  5                                   6    
  21  21 LEU B  119  SER B  130  1                                  12    
  22  22 ASP B  131  LEU B  142  1                                  12    
  23  23 GLY B  144  ILE B  155  1                                  12    
  24  24 PRO B  167  THR B  171  5                                   5    
  25  25 THR B  182  LEU B  195  1                                  14    
  26  26 GLY B  200  GLY B  213  1                                  14    
  27  27 SER B  220  LEU B  225  5                                   6    
  28  28 ARG B  275  GLY B  289  1                                  15    

>  <SHEET>
   1   A 5 GLN A  56  TYR A  60  0                                        
   2   A 5 ARG A  43  ASP A  50 -1  N  LEU A  48   O  VAL A  57           
   3   A 5 LEU A 259  THR A 266 -1  O  TYR A 264   N  GLY A  45           
   4   A 5 THR A 243  TRP A 251 -1  N  ILE A 250   O  LEU A 259           
   5   A 5 THR A 230  GLY A 238 -1  N  THR A 230   O  TRP A 251           
   1   B 2 PHE A  66  PRO A  67  0                                        
   2   B 2 THR A 180  THR A 181 -1  O  THR A 181   N  PHE A  66           
   1   C 2 PRO A  94  ILE A  97  0                                        
   2   C 2 GLY A 115  THR A 118 -1  O  GLY A 115   N  ILE A  97           
   1   D 5 GLN B  56  TYR B  60  0                                        
   2   D 5 ARG B  43  ASP B  50 -1  N  LEU B  48   O  VAL B  57           
   3   D 5 LEU B 259  THR B 266 -1  O  TYR B 264   N  GLY B  45           
   4   D 5 THR B 243  TRP B 251 -1  N  ILE B 250   O  LEU B 259           
   5   D 5 THR B 230  GLY B 238 -1  N  THR B 230   O  TRP B 251           
   1   E 2 PHE B  66  PRO B  67  0                                        
   2   E 2 THR B 180  THR B 181 -1  O  THR B 181   N  PHE B  66           
   1   F 2 PRO B  94  ILE B  97  0                                        
   2   F 2 GLY B 115  THR B 118 -1  O  GLY B 115   N  ILE B  97           

>  <LINK>
       OG  SER A  70                 B   2GK A 300     1555   1555  1.57  
       OG  SER B  70                 B   2GK B 300     1555   1555  1.61  

>  <CISPEP>
   1 GLU A  166    PRO A  167          0         5.43                     
   2 GLU B  166    PRO B  167          0         6.15                     

>  <SITE>
   1 AC1 13 CYS A  69  SER A  70  ASN A 104  TYR A 105                    
   2 AC1 13 SER A 130  ASN A 132  GLU A 166  ASN A 170                    
   3 AC1 13 THR A 235  GLY A 236  SER A 237  HOH A 433                    
   4 AC1 13 HOH A 634                                                     
   1 AC2 15 CYS B  69  SER B  70  LYS B  73  ASN B 104                    
   2 AC2 15 TYR B 105  SER B 130  ASN B 132  GLU B 166                    
   3 AC2 15 ASN B 170  THR B 216  LYS B 234  THR B 235                    
   4 AC2 15 GLY B 236  SER B 237  HOH B 614                               

>  <ORIGX1>
      1.000000  0.000000  0.000000        0.00000                         

>  <ORIGX2>
      0.000000  1.000000  0.000000        0.00000                         

>  <ORIGX3>
      0.000000  0.000000  1.000000        0.00000                         

>  <SCALE1>
      0.022165  0.000000  0.004723        0.00000                         

>  <SCALE2>
      0.000000  0.009381  0.000000        0.00000                         

>  <SCALE3>
      0.000000  0.000000  0.021444        0.00000                         

>  <MASTER>
      325    0    2   28   18    0    8    6 4715    2   36   42          

$$$$
